Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
Tiziana Life Sciences announced positive preclinical results demonstrating that their lead candidate, intranasal foralumab, a fully human anti-CD3 monoclonal antibody, can reduce neuroinflammation and improve cognition in aging-related models. These results support its potential use in treating neurodegenerative conditions and cognitive decline ass…